Monthly plans ship freeRead the terms

JournalDose and safety

Dose and safety, from the pouch and the research

What one gummy carries, how the pouch says to take it, what the safety studies found, and who should not take it.

By the THRYVE team4 min read

A THRYVE pouch on a walnut table with a phone and one gummy, beside a leather tray holding keys and glasses.

What one gummy carries

Each THRYVE gummy contains 30 mg of kanna extract, which the label gives as 5% alkaloids.1 A pouch holds 10 gummies, so 300 mg of extract in all.1 Every batch is tested by a third party, and the QR code on the back of the pouch is for its lab results.1

What the 5% measures, and so how many milligrams of alkaloids a gummy carries, is a question we have put to the supplier. Until it answers, we print the percentage and stop there.

How the pouch says to take it

The pouch gives three directions, quoted here as printed.1

Take 1 gummy daily as part of your morning routine to set your baseline.

For situational support, take another gummy 15-30 minutes before an occasional stressor.

Try 3 gummies for an evening unwind.

Its warning opens with four words that apply to all of it: effects vary by individual.1 That is a reason for the first gummy to fall on an ordinary morning, not on the day that counts.

The pouch prints no daily maximum.1 We will not print a number it does not.

Traditional intake, for context

A review reports a traditional intake of 500 to 1,500 mg of the plant a day, as it was chewed.2 That is a figure for a plant, not for an extract: history, not a recommendation and not a limit. It is printed for the record, and we do not convert it into gummies.

What the safety studies found

In a randomized, double-blind, placebo-controlled trial, 37 healthy adults took 8 mg or 25 mg of Zembrin, or a placebo, once a day for three months.3 Twelve took 8 mg, twelve took 25 mg and thirteen took the placebo, and both doses were well tolerated.3 Headache was the most common complaint, and it was more frequent on placebo.3

In rats, studies of Zembrin lasting 14 and 90 days found no adverse effects linked to the extract at the highest doses tested; the abstract does not give the group sizes.4 In laboratory assays, the extract showed no toxic effects on mammalian cells.5

A review published in 2021 found no reports to date of severe adverse reactions or herb-drug interactions.2

All of this is about Zembrin, a branded extract, tested in people, rats and cultured cells.345 None of it is safety data on a THRYVE gummy, and its milligrams describe that extract, not ours.1

Onset and duration

No published source gives kanna's typical onset or how long its effects last.67 The two placebo-controlled studies that timed their measures took them 2 hours after a 25 mg dose: one of Zembrin in 16 healthy adults, one of an unnamed extract given for 8 days to 60 trained adults.67

The pouch's direction, another gummy 15-30 minutes before an occasional stressor, is a timing to follow, not a measured onset.1 A time of measurement is not an onset either, and we do not read one into it.

Medication, pregnancy and age

The pouch is specific, and its warning closes this article, word for word: it says who should not use THRYVE at all, and who should consult a physician before use.1

The literature points the same way. A review published in 2021 advises caution with medication of the kind the pouch's second warning line names, and also flags medicines that act on the enzyme PDE4.2

THRYVE is for adults 21 and over, and the pouch belongs out of reach of children.1

The pouch says nothing about taking THRYVE with coffee or alcohol, and we will not fill that silence with a guess.

What we do not print

We do not print a daily maximum the pouch does not print, a milligram figure of alkaloids we cannot check, or an answer on drug tests that nobody has signed. Nor do we set a study's milligrams beside ours: they describe that study's extract. Each is a question for our supplier or for counsel, and each will be printed here once it has an answer in writing.

Drug tests

We do not have a signed answer on drug testing, so we will not guess at one. If you are tested for work, take the ingredient list on the ingredients page to whoever runs the program before your first gummy.

Who should not take it

The pouch is specific about this, and we quote it in full.

ADULTS 21+

WARNING: Effects vary by individual.

Do not use if you take an SSRI, SNRI, MAOI, tricyclic antidepressant, triptan, or any other medication that affects serotonin.

Consult a physician before use if you take any prescription medication, have a medical condition, or are pregnant or nursing.

Keep out of reach of children.

A review published in 2021 found no reports to date of severe adverse reactions or herb-drug interactions, and still advises caution with medication of the kind the second warning line names; it also flags medicines that act on the enzyme PDE4.2

* Marks a statement about what kanna or its alkaloids did in published research, or how a historical writer described it. None of it is a claim about this product.

[?]These statements made have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

References

Numbered in the order each source is first cited on this page. Titles are printed as their publishers printed them.

  1. THRYVE (client) (2026). THRYVE kanna gummies pouch: front, Supplement Facts, directions, warning. Back to the text
  2. Brendler T, Brinckmann JA, Feiter U, Gericke N, Lang L, Pozharitskaya ON, Shikov AN, Smith M, Van Wyk BE (2021). Sceletium for Managing Anxiety, Depression and Cognitive Impairment: A Traditional Herbal Medicine in Modern-Day Regulatory Systems. Current Neuropharmacology 19(9):1384-1400. doi:10.2174/1570159X19666210215124737 Back to the text
  3. Nell H, Siebert M, Chellan P, Gericke N (2013). A randomized, double-blind, parallel-group, placebo-controlled trial of Extract Sceletium tortuosum (Zembrin) in healthy adults. Journal of Alternative and Complementary Medicine 19(11):898-904. doi:10.1089/acm.2012.0185 Back to the text
  4. Murbach TS, Hirka G, Szakonyiné IP, Gericke N, Endres JR (2014). A toxicological safety assessment of a standardized extract of Sceletium tortuosum (Zembrin®) in rats. Food and Chemical Toxicology 74:190-199. doi:10.1016/j.fct.2014.09.017 Back to the text
  5. Harvey AL, Young LC, Viljoen AM, Gericke NP (2011). Pharmacological actions of the South African medicinal and functional food plant Sceletium tortuosum and its principal alkaloids. Journal of Ethnopharmacology 137(3):1124-1129. doi:10.1016/j.jep.2011.07.035 Back to the text
  6. Terburg D, Syal S, Rosenberger LA, Heany S, Phillips N, Gericke N, Stein DJ, van Honk J (2013). Acute effects of Sceletium tortuosum (Zembrin), a dual 5-HT reuptake and PDE4 inhibitor, in the human amygdala and its connection to the hypothalamus. Neuropsychopharmacology 38(13):2708-2716. doi:10.1038/npp.2013.183 Back to the text
  7. Hoffman JR, Markus I, Dubnov-Raz G, Gepner Y (2020). Ergogenic Effects of 8 Days of Sceletium Tortuosum Supplementation on Mood, Visual Tracking, and Reaction in Recreationally Trained Men and Women. Journal of Strength and Conditioning Research 34(9):2476-2481. doi:10.1519/JSC.0000000000003693 Back to the text

More from the journal

  1. The plant4 min readWhat kanna is
  2. Research4 min readHow kanna's alkaloids acted in published research
  3. History4 min readA short history of kanna